geria Flashcards

1
Q

aging (what’s not to be expected)

A

sickness, although common, isn’t part of the normal aging process; emphasis on this during pt. education

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

chronological vs biological age

A

chronological - your age in years from date of birth; biological age- your body’s age (affected by different factors, e.g., stress, disease/condition)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

body changes when we get older (10)

A
  • decrease in muscle performance (dec ms fiber size, fast-twitch fibers; loss of muscle mass; denervation of ms fibers, decline in total number)
  • dec bone tensile strength (more osteoclast, less osteoblasts) [bones get more brittle]
  • dec jt flexibility [less flexibility]
  • ms mass decline at 30 [less ms]
  • by 60-90, 30% of ms force production dec [less ms strength]
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

difference of fast-twitch and slow-twitch fibers

A

slow twitch (type I) - slow red ox
- aerobic, endurance exercises; oxygenated

fast-twitch - power / dynamic movement

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

osteopenia vs osteoporosis

A

osteopenia - less amount of bone density; osteoporosis - PROGRESSIVE LOSS of bone density
if untreated, osteopenia -> osteoporosis; major cause of fractures, MC women > men

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

osteosarcopenic obesity syndrome (what is it, describe the process and its components; is it reversible)

A

sarcopenia (loss of ms mass), osteopenia (loss of bone density), obesity (d/t myosteatosis AKA accumulation of fat in ms tissue)
- also: dynapenia (age-related loss of ms strength)
- these are normal processes in aging that can be addressed but if these 3 are left unchecked they will lead to osteosarcopenic obesity syndrome (NOT normal)

reversible unlike cachexia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sarcopenia vs cachexia

A

cachexia - loss of ms mass with or w/o fat loss; weight loss usually associated w end-stage diseases; body is wasting away and eating at itself, towards the end of this, pt. usually has to rely on caregivers for basic functions (total dependence); exercise has no effect
sarcopenia - reversible, MC men > women; ms mass loss; can be reversed by training

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

changes in collagen fibers during aging (4)

A
  • less water in collagen matrix => less shock absorption properties, loss of collagen in IV discs (get shorter/smaller)
  • inc crosslinks => scar tissue-like, not as pliable
  • dec elastic fibers = skin sagging
  • dec ROM - fine as long as fxal
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CV changes during aging and consequences (6-9)

A
  • dec HRmax & vo2max- dec aerobic workload capacity
  • stiffer vascular tissue - inc BP, dec cardiac output and ventricle filling
  • dec contractility in vasc tissue - dec HR, vo2max, aerobic workload capacity
  • loss of cells in SA node - dec HR & HR max
  • thickened basement membrane in capillary - dec arteriovenous o2 uptake
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

neurologic system changes during aging (5-6)

A
  • loss of myelin - slowed nerve conduction
  • axonal loss - slower ms fibers, loss of fine sensation
  • ANS dysfunc - systemic issues (e.g., CV and GI systems)
  • loss of sensory neurons - dec ability to discern of temperature and pain
  • slower response time - inc fall risk
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

cognitive changes during aging (5)

A
  • slower info processing
  • delays in processing & task execution, learning, and long-standing tasks
  • higher cognitive reserves in younger years serve as a neuroprotective resource when we get older (more grey and white matter reserves)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

process leading to ADRs (3)

A
  • altered distribution and absorption of drugs, impaired metabolizing of liver, difficulty in excretion => altered drug response and side-effects

distribution - less motile, absorption area, stomach emptying and gastric acid
absorption - less water, ms mass and plasma protein; inc fat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

polypharmacy vs ADR

A

ADR - physiological response
polypharmacy - behavioral; excessive/inappropriate use of drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

vicious cycle of drug administration (5)

A

more illness/conditions -> medications taken for conditions -> medications have side-effects -> side-effects are seen as sx. -> more medication taken for those side-effects (cycle repeats)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

common ADRs (10) describe (common sx, mechanism, common meds, PT indications)

A

GI-S-FW-C-A-D-E-E-D-OH
GI issues
- vomiting, nausea, diarrhea, constipation
- NSAIDs, opioids: inhibit both cox inhibitors (inhibition of cox 1 leads to GI bleeding bc dec in mucosal lining)
- antibiotics: mess up gut fauna
- cox 2 inhibitors (eg. celecoxib, celebrex - increase MI risk)
sedation
- sleepiness, drowsiness
- analgesics, sedative-hypnotics, antihistamines, benzos, barbs
- dont lift heavy weights
fatigue & weakness
- ms weakness (more relaxed), less water and electrolytes
- diuretics, HTN meds (-zide, -zone)
confusion
- mild confusion to delirium
- antidepressants, drugs w anticholinergic effect (parasympathetic NS activity), narcotics, analgesics
depression
- barbs, antipsychotics, anti-HTN drugs (clonidine, propanolol, reserpine)
- clonidine: decreases catecholamine output -> inhibition of sympathetic NS
- reserpine: sympatholytic -> directly depresses sympathetic NS
excessive bleeding
- anti-HTN meds (i.e., anti-platelet meds)
extrapyramidal effects
- tardive dyskinesia, dystonia, pseudoparkinsonism
- antipsychotics
anticholinergic effects
- antihistamines, antipsychotics, anticholinergic drugs
- CNS effects (drowsy, dizzy) some PNS (sympathetic activated sx
OH
- anti-HTN, anti-anginal meds
- inc risk for falls
dizziness & falls
- sedation and OH-inducing drugs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

frailty hallmarks (5)

A
  • at least 3/5: (less than 3 pre-frail)
    1. weight loss (10 lbs > in a year)
    2. exhaustion
    3. weak grip strength
    4. low PA
    5. slow walking speed
17
Q

MC cause of injury and leading cause of injury death in persons 65+

A

falls

18
Q

5 types of fallers

A
  • accidental versus nonaccidental,
  • syncopal versus nonsyncopal (fainted vs not),
  • intrinsically versus extrinsically driven,
  • falls with injury versus falls without injury
  • single fall incident versus recurrent falling
19
Q

criteria for recurrent faller

A

at least 2 falls in the last 6-12mos

20
Q

FOF (causes, what to do, mechanisms that affect it)

A

causes: previous falls, injury
what to do: dethreaten movement
mechanisms that can affect: “freezing episodes”

21
Q

MCI (difference to dementia, and hallmarks (4), types (2))

A

mci lies bet normal ageing and dementia
- abnormal cognitive measures compared to population-related norms
- doesn’t affect ADLs
- normal gen cognitive fxn
- memory complaints

amnestic vs non amnestic

22
Q

delirium vs dementia

A

dementia - condition, progressively worsening degenerative of cognitive processes, irreversible; start with sx of mci and delirium
delirium - sudden onset, state (transient); can be agitated or hypoactive ; can happen in isolation

23
Q

essential feature of dementia (2-4)

A
  • devt of multiple cognitive deficits and at least 1 of the ff: agnosia, aphasia, apraxia, disturbance in executive fxning
24
Q

types of apraxia (2) and aphasia (2)

A

ideational apraxia (lost idea of task) and ideomotor aphasia (can physically do task but cannot process cue)

broca’s aphasia (motor issue when speaking) and wernicke’s aphasia (cognitive issue - speech doesnt make sense)

25
Q

types of dementia (4) (origin, clinical sx)

A
  1. lewy body
    - d/t build-up of a-synuclein protein
    - visual hallucination, parkinsonian sx., sensitive to antipsychotics
  2. frontotemporal
    - buildup of proteins in frontotemporal regions
    - personality, thinking, judgment
  3. alzheimers
    - MC, d/t build-up of beta-amyloid proteins and neurofibrillary tangles (build-up of tau protein), loss of white matter
    - memory, sx more severe w stress/tiredness (sundowning), aphasia, confusion/getting lost, lack of insight
  4. vascular
    - depending on area of infarct (small vessel, larger areas [multiple infarcts]); the only one that is SPONTANEOUS
    - depending on the area, slowed thinking/cognitive processes
26
Q

stages of AD devt in order (9)

A
  1. Early stages: [memory impairments!!], lapses in judgment, subtle changes in personality
  2. depression d/t awareness of cognitive decline
  3. IADLs difficulty (memory and language )
  4. getting lost, visuospatial probs
  5. disoriented, delusional, hostile
  6. motor control fxn loss
  7. behavioral probs
  8. dysphagia + incontinence
  9. not remembering family members and difficulty speaking
    - death bc brain shrinks and organ shuts down

EDIGDMBDN

27
Q

lewy body dementia (how common, sx, cause)

A

a-synuclein protein build-up
one of the most common progressive dementias
- progressive cognitive decline and 3 addtnal features:
1. fluctuations in alertness and attention
2. visual hallucination
3. parkinson-like sx. (EXTRA-pyramid)

28
Q

karvonen

A

220-age= MHR
((MHR-RHR)(target intensity)) +RHR = THR

29
Q

RPE table (mRPE, RPE, % effort, perceived workload, talk test)

A

6, 7, 8- 20, 30, 40
1- 9- 50- very very light - rest
2 - 10 - 55
3- 11 - 60 - fairly light - strolling
12- 65 -
4 - 13 - 70 - somewhat hard - brisk walking
- 14 - 75 -
5 - 15 - 80 - hard - 4-5 words
16 - 85
7 - 17 - 90 - very hard - cant talk
8 - 18 - 95 -
9 - 19 - 100
10 - 20 - exhaustion

30
Q

norms for 6MWT (community ambu, walking speed)

A

300-400m = community ambu
0.8-1.5 m/s = fast enough to cross street

31
Q

fun, function, frail, failure values for gait speed, 6mwt, 30STS, SCT, floor transfer

A

gait speed: fxn: 0.8-1.5m/s; frail 0.3-0.8m/s
6MWT: fxn: 300-400m; frail: 200-350m
30STS: fxn: 8-15; frail: <8
CST: fxn: 10-30s; frail: 30-50s
floor transfer - fxn: 10-30s; frail: >30s

32
Q

balance and gait tests cut-off scores (8)

A

B46, T19, TUG13, 4S5S15, DGI20, FGA22, ABC67

33
Q

recommended intensity

A

not lower than 60% intensity or 15RM

34
Q

reactive balance control strategies (3)

A

hip, ankle, stepping strategy

35
Q

primary goals for dementia management (2)

A

improve quality, maximize functional performance

36
Q

main goals of PT in dementia mgmt (3)

A
  1. assist pt., caregiver, family to maximize functional performance and slow down physical decline
  2. simplifying or modifying envt to help with activity performance
  3. help caregivers create safe, functional, meaningful and pleasant activities
37
Q

approach for dementia pt.s w behavioral issues

A

antecedent-behavior-consequence (ABCs)

38
Q

contraindications for exercise (3 absolute CIs and 6 general precautions)

A

absolute CIs: RHR above 100, systolic above 200mmHg/diastolic above 120mmHg, stretching-jt. instability
- use safety equipment if needed
- proper form, avoid valsalva/holding breath
- safe envt (not too hot, cluttered, etc.)
- never exercise unsupervised in high intensity (min. 75-90% 1RM)
- know their meds, possible side effects
- provide encouragement